Limin Lun

744 total citations
36 papers, 515 citations indexed

About

Limin Lun is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Limin Lun has authored 36 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Limin Lun's work include Cancer-related molecular mechanisms research (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and RNA modifications and cancer (4 papers). Limin Lun is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), Nitric Oxide and Endothelin Effects (4 papers) and RNA modifications and cancer (4 papers). Limin Lun collaborates with scholars based in China, United States and Norway. Limin Lun's co-authors include Chao Xuan, Guo‐Wei He, Qingwu Tian, Qing Wang, Beibei Zhang, Guoqiang Du, Juan Wang, Zhonghang Xu, Zhe Wang and Yunyuan Zhang and has published in prestigious journals such as Scientific Reports, Molecules and Journal of the American Academy of Dermatology.

In The Last Decade

Limin Lun

35 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Limin Lun China 14 209 109 79 79 68 36 515
Jia Peng China 12 282 1.3× 139 1.3× 107 1.4× 95 1.2× 157 2.3× 27 782
Keita Mori Japan 13 223 1.1× 58 0.5× 73 0.9× 48 0.6× 70 1.0× 32 594
Yunfeng Xia China 15 225 1.1× 40 0.4× 68 0.9× 58 0.7× 77 1.1× 37 643
Zhaoya Liu China 13 306 1.5× 203 1.9× 44 0.6× 85 1.1× 60 0.9× 26 656
Magdalena Białas Poland 13 142 0.7× 79 0.7× 83 1.1× 86 1.1× 176 2.6× 50 530
Chongxiang Xiong China 18 314 1.5× 46 0.4× 61 0.8× 110 1.4× 128 1.9× 36 767
Mao Liu China 15 194 0.9× 91 0.8× 36 0.5× 35 0.4× 99 1.5× 56 554
Ann Van Campenhout Belgium 11 282 1.3× 52 0.5× 116 1.5× 45 0.6× 100 1.5× 14 680

Countries citing papers authored by Limin Lun

Since Specialization
Citations

This map shows the geographic impact of Limin Lun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limin Lun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limin Lun more than expected).

Fields of papers citing papers by Limin Lun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Limin Lun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limin Lun. The network helps show where Limin Lun may publish in the future.

Co-authorship network of co-authors of Limin Lun

This figure shows the co-authorship network connecting the top 25 collaborators of Limin Lun. A scholar is included among the top collaborators of Limin Lun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Limin Lun. Limin Lun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chang, Jui‐Wen, Wenjing Jiang, Limin Lun, et al.. (2025). Abrocitinib versus dupilumab: Impact on skin barrier function and proteomics in atopic dermatitis. Journal of the American Academy of Dermatology. 93(2). 406–414. 1 indexed citations
2.
3.
Xu, Rui, Limin Lun, Wenjing Jiang, et al.. (2024). Engineering a halloysite nanotube-enhanced hydrogel 3D skin model for modulated inflammation and accelerated wound healing. Bioactive Materials. 45. 148–161. 2 indexed citations
4.
Wang, Huan, Hui Li, Yan Wang, et al.. (2023). Hematological parameters and early-onset coronary artery disease: a retrospective case–control study based on 3366 participants. Therapeutic Advances in Chronic Disease. 14. 374191246–374191246. 10 indexed citations
5.
Wang, Juan, Limin Lun, Xin Jiang, et al.. (2021). APE1 facilitates PD-L1-mediated progression of laryngeal and hypopharyngeal squamous cell carcinoma. International Immunopharmacology. 97. 107675–107675. 12 indexed citations
6.
Xuan, Chao, Hui Li, Qingwu Tian, et al.. (2021). Quantitative Assessment of Serum Amino Acids and Association with Early-Onset Coronary Artery Disease. Clinical Interventions in Aging. Volume 16. 465–474. 12 indexed citations
7.
Xuan, Chao, Qingwu Tian, Hui Li, et al.. (2021). Serum fatty acids profile and association with early-onset coronary artery disease. Therapeutic Advances in Chronic Disease. 12. 364081678–364081678. 4 indexed citations
8.
Feng, Xiaodong, Zhiwei Zheng, Yi Wang, et al.. (2020). Elevated RUNX1 is a prognostic biomarker for human head and neck squamous cell carcinoma. Experimental Biology and Medicine. 246(5). 538–546. 10 indexed citations
9.
Zhang, Shaoyan, Chao Xuan, Jie Zhu, et al.. (2019). Association Between MTHFR Gene Common Variants, Serum Homocysteine, and Risk of Early-Onset Coronary Artery Disease: A Case–Control Study. Biochemical Genetics. 58(2). 245–256. 11 indexed citations
10.
Chen, Xian, Limin Lun, Qingwu Tian, et al.. (2019). LncRNA PANDAR is a Novel Prognostic Biomarker in Patients with Cancer: a Meta-Analysis. Clinical Laboratory. 65(01+02/2019).
11.
Tian, Tingting, Qing Wang, Qingwu Tian, et al.. (2018). Serum Uric Acid as an Independent Risk Factor for the Presence and Severity of Early-Onset Coronary Artery Disease: A Case-Control Study. Disease Markers. 2018. 1–8. 25 indexed citations
12.
13.
Zhang, Yunyuan, Limin Lun, Hui Li, et al.. (2017). The Value of lncRNA NEAT1 as a Prognostic Factor for Survival of Cancer Outcome: A Meta-Analysis. Scientific Reports. 7(1). 13080–13080. 27 indexed citations
14.
Xuan, Chao, Zhenfang Liu, Qing Wang, et al.. (2016). Increased serum concentrations of asymmetric dimethylarginine (ADMA) in patients with early-onset coronary artery disease. Clinica Chimica Acta. 464. 195–199. 19 indexed citations
15.
Zhang, Yunyuan, Limin Lun, Qing Wang, et al.. (2016). Diagnostic accuracy of CD44V6 for osteosarcoma: a meta-analysis. Journal of Orthopaedic Surgery and Research. 11(1). 133–133. 8 indexed citations
16.
Zhang, Yunyuan, Jun Zhou, Sun Meiling, et al.. (2016). Prognostic Value of microRNA-9 in Various Cancers: a Meta-analysis. Pathology & Oncology Research. 23(3). 573–582. 4 indexed citations
17.
18.
Xuan, Chao, Hui Li, Hongwei Wang, et al.. (2014). Association Between MTHFR Polymorphisms and Congenital Heart Disease: A Meta-analysis based on 9,329 cases and 15,076 controls. Scientific Reports. 4(1). 7311–7311. 38 indexed citations
19.
Tian, Qingwu, Chao Xuan, Hongwei Wang, et al.. (2013). Diagnostic Accuracy of Glycosylated Hemoglobin in Chinese Patients with Gestational Diabetes Mellitus: A Meta-Analysis Based on 2,812 Patients and 5,918 Controls. Genetic Testing and Molecular Biomarkers. 17(9). 687–695. 13 indexed citations
20.
Pan, Huazheng, Jun Liang, Yu Zhuang, et al.. (2011). Polymorphism of DNA repair gene XRCC1 and hepatocellular carcinoma risk in Chinese population.. PubMed. 12(11). 2947–50. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jia Peng Breakdown of academic impact, for papers by Keita Mori Breakdown of academic impact, for papers by Yunfeng Xia Breakdown of academic impact, for papers by Zhaoya Liu Breakdown of academic impact, for papers by Magdalena Białas Breakdown of academic impact, for papers by Chongxiang Xiong Breakdown of academic impact, for papers by Mao Liu Breakdown of academic impact, for papers by Ann Van Campenhout
Rankless by CCL
2026